Evidence map›Paper›PMID 41286687›Full record

ArticleBMC public health2025

Heterogeneous impact of fine particulate matter constituents on pulmonary tuberculosis onset: a multicenter time series study in Beijing.

Shirong Li, Feng Guo, Chao Wang, Rongmei Liu, Wenjie Qi

Abstract readMulticenter Study
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shirong Li *Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, No.95 Yong 'an Road, Xicheng District, Beijing, 100050, China.
Feng Guo *The second clinical medical college, Capital Medical University, Beijing, China.
Chao WangDepartment of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, No.95 Yong 'an Road, Xicheng District, Beijing, 100050, China.
Rongmei LiuDepartment of Research Ward, Beijing Chest Hospital, Capital Medical University, No. 97 Ma Chang, Tongzhou District, Beijing, 101149, China. Lrongmei@163.com.
Wenjie QiDepartment of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, No.95 Yong 'an Road, Xicheng District, Beijing, 100050, China. qi_wenjie@ccmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological studies have implicated exposure to PM₂.₅ in the development of pulmonary tuberculosis (PTB); however, the key constituents driving this effect have not been clearly identified.

methodsA time-series analysis spanning 2019 to 2023 was performed across several centers in Beijing to assess the links between major PM

resultsAll five examined components demonstrated significant relationships with an elevated risk of PTB. Associations were not statistically significant on the same day (lag 0) or the next day (lag 1) after exposure. A clear risk increase was detected starting at a 2-day lag, which was no longer observable by lag 3. Per interquartile range (IQR) rise in the 3-day moving average (lag 0-2) of black carbon and organic matter, the relative risks (RRs) for PTB were 1.11 [95% confidence interval (CI): 1.03, 1.19] and 1.11 (95% CI: 1.03, 1.21), correspondingly. Together, these two components were the dominant drivers of the overall PM₂.₅ effect, contributing 41% and 39% of the joint risk, respectively.

conclusionsThe results yield novel evidence that exposure to certain PM

Indexed as

Air PollutantsEnvironmental ExposureParticulate MatterTuberculosis, PulmonaryBeijingHumansMaleAir PollutantsParticulate MatterFine particulate matter constituentsFine particulate matter constituents variationMulticenter studyPulmonary tuberculosisTime-series study

Identifiers

PMID41286687
PMCPMC12642183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.